
Periods
Irregular Periods and PCOS: Why They Happen and When to Worry
Why PCOS makes periods late or stop, the exact cycle lengths that count as irregular, when a long gap becomes a risk, and what actually helps.
By Dr. Parikshit Verma · 10 min read
Quick answer
Women with PCOS have a higher risk of type 2 diabetes, whatever their age or weight. The 2023 international PCOS guideline advises checking blood sugar at diagnosis and then every 1 to 3 years, depending on other risk factors. It prefers the oral glucose tolerance test, because fasting glucose and HbA1c can miss some cases.
Tvarvi Key Takeaways
Why blood sugar matters in PCOS
- The higher risk applies at any age and any weight.
- Raised blood sugar often causes no symptoms at first.
- Studies from Asia found a larger rise in risk.
Which test a doctor may suggest
- The oral glucose tolerance test is the guideline's preferred test.
- It involves a glucose drink and a blood test 2 hours later.
- Fasting glucose and HbA1c are less accurate in PCOS.
How often to check
- Once when PCOS is diagnosed.
- Again every 1 to 3 years, based on your own risk factors.
- Before a planned pregnancy, the guideline suggests a glucose test.
In this article
Yes. The 2023 International Evidence-based Guideline for PCOS states that, regardless of age and BMI, women with PCOS have an increased risk of impaired fasting glucose, impaired glucose tolerance and type 2 diabetes.
The WHO fact sheet on PCOS describes PCOS as a chronic metabolic condition that persists beyond the reproductive years, and says women with PCOS are at higher risk of longer-term health problems including insulin resistance, type 2 diabetes and obesity.
The size of the difference comes from pooled studies. A 2018 meta-analysis of 40 studies in Human Reproduction Update by Kakoly and colleagues found that women with PCOS had about three times the odds of impaired glucose tolerance and of type 2 diabetes compared with women without PCOS.
The same meta-analysis found that these blood sugar problems were more common with obesity. This higher risk is why the 2023 guideline includes a PCOS diabetes test, a check of blood sugar status, at diagnosis for every adult and teenager with PCOS.
How weight and insulin fit together in PCOS is covered in our main guide to PCOS and weight gain.
For India, the ICMR-funded nationwide study by Ganie and colleagues (2024) enrolled 8,993 women aged 18 to 40 across 5 zones of India and identified PCOS by the NIH 1990, Rotterdam 2003 or AE-PCOS criteria.
Among the 1,224 women with PCOS, the ICMR study found impaired glucose tolerance in 9.1% and diabetes in 3.3%.
The same study also looked at 492 women with only one PCOS feature (a group it called pre-PCOS), and found impaired glucose tolerance in 12.6% of them.
The Kakoly meta-analysis found that the higher rate of impaired glucose tolerance in PCOS was about five-fold in studies from Asia, compared with about three-fold in Europe, and that the difference for Asia held even when women of similar BMI were compared.
Raised blood sugar can be present without any signs. The StatPearls clinical reference on prediabetes notes that adults with prediabetes often may show no signs or symptoms of diabetes, and that many people are not aware they are living with prediabetes.
That is why the 2023 guideline recommends that blood sugar (glycaemic) status is assessed at diagnosis in all adults and adolescents with PCOS.
The guideline also asks healthcare professionals, women with PCOS and their first-degree relatives (close family, such as parents and siblings) to be aware of the higher diabetes risk and of the need for regular blood sugar checks.
The OGTT checks whether your body can use and store glucose normally. In the StatPearls clinical reference on the glucose tolerance test, a standard dose of glucose is taken by mouth and blood levels are measured 2 hours later.
The 2023 guideline recommends the 75-g OGTT as the test to assess blood sugar status in PCOS, regardless of BMI, and describes it as more accurate than fasting glucose or HbA1c. Your doctor or the lab will tell you how to prepare for it.
Table 1. The blood sugar tests named in the 2023 PCOS guideline
| Test | What it involves | What the guideline says |
|---|---|---|
| Oral glucose tolerance test (OGTT) | A glucose drink, then a blood test 2 hours later | Recommended as the more accurate test, whatever your BMI |
| Fasting plasma glucose | One blood sugar reading taken after fasting | Could be considered if an OGTT cannot be done, with much lower accuracy |
| HbA1c | One blood test that reflects average blood sugar over about the past 90 days | Could be considered if an OGTT cannot be done, with much lower accuracy |
| Insulin blood tests | A blood test for insulin levels | Of limited clinical relevance and not recommended in routine care |
Source: Teede et al., Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of PCOS, J Clin Endocrinol Metab, 2023; test descriptions from StatPearls, Glucose Tolerance Test and StatPearls, Hemoglobin A1C.
A single reading can miss some cases that the OGTT picks up. The 2023 guideline says that if an OGTT cannot be done, fasting plasma glucose or glycated haemoglobin (HbA1c) could be considered, noting their significantly reduced accuracy.
HbA1c works differently from a glucose test: the StatPearls clinical reference on HbA1c explains that it shows average blood sugar levels over the past 90 days, expressed as a percentage.
The evidence behind this advice comes from a 2024 systematic review and meta-analysis by Belsti and colleagues, which pooled 9 studies of 2,628 women with PCOS and compared HbA1c and fasting plasma glucose against the OGTT.
It found that using the HbA1c cut-off for diabetes may result in misdiagnosis of half of the women with type 2 diabetes, and that fasting plasma glucose also missed many of the cases the OGTT found.
The authors of that review state that their results directly informed the 2023 guideline's preference for the OGTT. The guideline rates the certainty of the evidence behind its test advice as very low, which the guideline defines as very little confidence in the estimate.
Insulin tests are a separate question. The 2023 guideline says clinically available insulin assays are of limited clinical relevance and are not recommended in routine care; read more in our guide to insulin resistance in women.
The 2023 guideline recommends checking blood sugar status at diagnosis, then again every 1 to 3 years, based on additional individual risk factors for diabetes.
This interval is a consensus recommendation: the guideline explains that consensus recommendations are made by its expert group where evidence is not adequate, informed by evidence from the general population.
The recommendation bases the gap on your additional individual risk factors for diabetes, so your doctor weighs your own situation. The Kakoly meta-analysis found that the extra risk in PCOS was higher with obesity and differed by ethnicity, with about five-fold higher odds for impaired glucose tolerance in studies from Asia.
Lean women are included as well: the guideline states the higher risk applies regardless of BMI, and recommends the OGTT regardless of BMI. Our article on lean PCOS covers PCOS at a lower weight.
Our page on PCOS blood tests explains how a doctor may choose the tests that fit your situation.
Pregnancy brings its own blood sugar risk in PCOS. The 2023 guideline recommends that an OGTT is considered in all women with PCOS without existing diabetes when planning a pregnancy or seeking fertility treatment, given the high risk of raised blood sugar in pregnancy.
If it is not done before pregnancy, the guideline says an OGTT should be offered at the first antenatal visit, and all women with PCOS should be offered the test at 24 to 28 weeks of pregnancy.
The WHO fact sheet lists gestational diabetes (diabetes that starts in pregnancy) among the conditions women with PCOS have a higher risk of. If you are planning a pregnancy, a gynaecologist can talk you through the options.
A result is a starting point for a conversation with your doctor. The 2023 guideline asks healthcare professionals and women with PCOS to prioritise preventive steps that reduce the risk of type 2 diabetes.
The guideline also notes that women with type 1 or type 2 diabetes have a higher risk of PCOS, so the link runs both ways.
If you have PCOS and have not had your blood sugar checked, a gynaecologist can talk you through the tests that fit your situation.
Can teenagers with PCOS have their blood sugar checked? Yes. The 2023 International PCOS Guideline recommends that blood sugar status is assessed at diagnosis in adolescents as well as adults with PCOS. If you are a teenager, it helps to see a gynaecologist with a parent or guardian.
Does having diabetes raise the chance of PCOS? The 2023 guideline states that women with type 1 and type 2 diabetes have an increased risk of PCOS, and that screening for PCOS should be considered in people with diabetes.
Should family members of women with PCOS know about the diabetes risk? The 2023 guideline says that first-degree relatives should be aware of the increased risk of diabetes, and that healthcare professionals could consider that fathers and brothers of women with PCOS may have a higher rate of type 2 diabetes.
Is PCOS counted as a risk factor in diabetes guidelines? The 2023 PCOS guideline recommends that general diabetes guidelines consider including PCOS as an independent risk factor for diabetes.
This article is general health information and does not replace a consultation about your own health. Medical decisions depend on your individual situation and should be made with a registered doctor. If you are struggling with your mood, Tele MANAS (14416) is free and open all day.
Think this might be you?
Start your PCOS Assessment (₹1,490) - a gynaecologist consult plus the blood tests your answers call for, collected from your home. Or ask us a question first.
Science-backed health resources.